Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: the ESPARTA study
Abstract
Aim: To analyze the use of oral anticoagulants in elderly patients with atrial fibrillation in clinical practice. Patients & methods: Cross-sectional and multicenter study performed in atrial fibrillation patients ≥75 years treated with oral anticoagulants ≥3 months. Results: 837 patients (83.0 ± 5.0 years; CHA2DS2-VASc 5.0 ± 1.4; HAS-BLED 2.1 ± 0.9; 70.8% vitamin K antagonists; 29.2% direct oral anticoagulants [DOACs]) were included. Poor adherence was observed in 27.9% of patients. Higher scores in the Pfeiffer’s test and FRAIL scale were associated with poorer adherence. Among patients treated with DOACs, 62.3% received the lower doses. Having high CHADS2 score and being older were associated with the use of low doses. Conclusion: 28% of patients had a poor adherence to anticoagulant treatment. 62% of patients were treated with the lower doses of DOACs.
Supplementary Material
File (suppl_tables.docx)
- Download
- 29.59 KB
References
Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Morin DP, Bernard ML, Madias C, Rogers PA, Thihalolipavan S, Estes NA 3rd. The state of the art: atrial fibrillation epidemiology, prevention, and treatment. Mayo Clin. Proc. 91(12), 1778–1810 (2016).
2.
Wang Y, Singh S, Bajorek B. Old age, high risk medication, polypharmacy: a ‘trilogy’ of risks in older patients with atrial fibrillation. Pharm. Pract. (Granada) 14(2), 706 (2016).
3.
Nguyen TN, Cumming RG, Hilmer SN. The impact of frailty on mortality, length of stay and re-hospitalisation in older patients with atrial fibrillation. Heart Lung. Circ. 25(6), 551–557 (2016).
• Showed that frailty was common in older inpatients with atrial fibrillation (AF) and was associated with poorer outcomes.
4.
Formiga F, Ferrer A, Mestre D, Brasé A, Soldevila L, Corbella X. High rate of mortality in Spanish community-dwelling population aged 85 with atrial fibrillation after three years of follow-up: the Octabaix study. Australas. J. Ageing 35(3), 216–219 (2016).
5.
da Silva RM. Atrial fibrillation: epidemiology and peculiarities in the elderly. Cardiovasc. Hematol. Agents. Med. Chem. 13(2), 72–77 (2015).
6.
Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 37(38), 2893–2962 (2016).
7.
Suárez Fernández C, Formiga F, Camafort M et al. Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach. BMC Cardiovasc. Disord. 15, 143 (2015).
8.
Hugo GS, Figueiras-Graillet LM, Anguita M et al. Oral anticoagulation in octogenarians with atrial fibrillation. Int. J. Cardiol. 223, 87–90 (2016).
• This registry showed that vitamin K antagonists anticoagulation quality was similar in octogenarians than in younger patients.
9.
Karamichalakis N, Georgopoulos S, Vlachos K et al. Efficacy and safety of novel anticoagulants in the elderly. J. Geriatr. Cardiol. 13(8), 718–723 (2016).
10.
Tanislav C, Milde S, Schwartzkopff S, Misselwitz B, Sieweke N, Kaps M. Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice. BMC Res. Notes 8, 262 (2015).
11.
Garkina SV, Vavilova TV, Lebedev DS, Mikhaylov EN. Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants. J. Geriatr. Cardiol. 13(9), 807–810 (2016).
• Showed that elderly patients with AF usually have more concomitant conditions that affect compliance and adherence to anticoagulant therapy and that direct oral anticoagulants have a better adherence.
12.
Heidbuchel H, Verhamme P, Alings M et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17(10), 1467–1507 (2015).
13.
Agencia Española de Medicamentos y Productos Sanitarios. Therapeutic Positioning Report UT/V4/23122013. Criteria and general recommendations for the use of new oral anticoagulants in the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/criterios-anticoagulantes-orales.pdf
14.
Mostaza JM, Cantero J, Surinach JM et al. Adherence to recommendations about treatment with oral anticoagulants in elderly patients with atrial fibrillation. The ESPARTA study. Rev. Esp. Cardiol. (2017) (Epub ahead of print).
15.
Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 137(2), 263–272 (2010).
16.
Pisters R, lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5), 1093–1100 (2010).
17.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 40(5), 373–383 (1987).
18.
Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 23(10), 433–441 (1975).
19.
Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A. Biol. Sci. Med. Sci. 56(3), M146–M156 (2001).
20.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care 24(1), 67–74 (1986).
21.
Pulignano G, Del Sindaco D, Tinti MD et al. Atrial fibrillation management in older heart failure patients: a complex clinical problem. Heart Int. 11(1), e41–e49 (2016).
22.
Kailas SD, Thambuluru SR. Efficacy and safety of direct oral anticoagulants compared to warfarin in prevention of thromboembolic events among elderly patients with atrial fibrillation. Cureus 8(10), e836 (2016).
23.
Proietti M, Nobili A, Raparelli V et al. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study. Clin. Res. Cardiol. 105(11), 912–920 (2016).
•• Showed that nonadherence to guidelines was highly prevalent among elderly AF patients.
24.
Lip GY, Laroche C, Popescu MI et al. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. Europace 17(12), 1777–1786 (2015).
25.
Lam WY, Fresco P. Medication adherence measures: an overview. Biomed. Res. Int. 2015, 217047 (2015).
26.
Basaran O, Filiz Basaran N, Cekic EG et al. PRescriptiOn PattERns of oral anticoagulants in nonvalvular atrial fibrillation (PROPER study). Clin. Appl. Thromb. Hemost. 23(4), 384–391 (2017).
27.
Larock AS, Mullier F, Sennesael AL et al. Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study. Ann. Pharmacother. 48(10), 1258–1268 (2014).
Information & Authors
Information
Published In
Copyright
© 2018 Future Medicine Ltd.
History
Received: 19 May 2017
Accepted: 18 September 2017
Published online: 21 February 2018
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: the ESPARTA study. (2018) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2017-0034
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Aashiq Ahamed Shukkoor, Ricky D Turgeon, Mary A De Vera, Mark Harrison, Nimmy Elizabeth George, Peter S Loewen, Association of ischaemic stroke/TIA with subsequent oral anticoagulant adherence in patients with atrial fibrillation: a scoping review, BMJ Open, 10.1136/bmjopen-2025-112736, 16, 6, (e112736), (2026).
- Toshiaki SUDOH, Nobuyoshi KURIHARA, Seiichi KATOH, Taito HONDA, Kana OHSHIMA, Satoko KAMAI, Ryota TANAKA, Yasushi IMAI, Medication Adherence Survey during Anticoagulant Therapy, Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 10.3999/jscpt.56.2_81, 56, 2, (81-87), (2025).
- José Guillermo Colchado Vallejos, Gonzalo Daniel Quirós López, Tania Tello Rodríguez, Henry Anchante Hernández, Frailty prevalence in older adults with atrial fibrillation: A cross-sectional study in a resource-limited setting, PLOS ONE, 10.1371/journal.pone.0312498, 19, 10, (e0312498), (2024).
- Fabiana Lucà, Fabrizio Oliva, Maurizio Giuseppe Abrignani, Stefania Angela Di Fusco, Iris Parrini, Maria Laura Canale, Simona Giubilato, Stefano Cornara, Martina Nesti, Carmelo Massimiliano Rao, Andrea Pozzi, Giulio Binaghi, Alessandro Maloberti, Roberto Ceravolo, Irma Bisceglia, Roberta Rossini, Pier Luigi Temporelli, Antonio Francesco Amico, Raimondo Calvanese, Sandro Gelsomino, Carmine Riccio, Massimo Grimaldi, Furio Colivicchi, Michele Massimo Gulizia, Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios, Journal of Clinical Medicine, 10.3390/jcm12185955, 12, 18, (5955), (2023).
- Vanelise Zortea, Karine Duarte Curvello, Diogo Pilger, Antonios Douros, Lisiane Freitas Leal, Tatiana da Silva Sempé, Tatiane da Silva Dal Pizzol, Adherence and Quality of Life in Non-Valvular Atrial Fibrillation With Direct Oral Anticoagulants Versus Vitamin K Antagonists: A Systematic Review, International Journal of Cardiovascular Sciences, 10.36660/ijcs.20220115, 36, (2023).
- E. Rodilla, M.I. Orts-Martínez, M.A. Sanz-Caballer, M.T. Gimeno-Brosel, M.J. Arilla-Morel, I. Navarro-Gonzalo, I. Castillo-Valero, I. Salvador-Mercader, A. Carral-Tatay, Patterns and outcomes of switching direct oral anticoagulants in non-valvular atrial fibrillation: A real-world experience from Spain, Revista Clínica Española (English Edition), 10.1016/j.rceng.2023.04.005, 223, 6, (340-349), (2023).
- E. Rodilla, M.I. Orts-Martínez, M.Á. Sanz-Caballer, M.T. Gimeno-Brosel, M.J. Arilla-Morel, I. Navarro-Gonzalo, I. Castillo-Valero, I. Salvador-Mercader, A. Carral-Tatay, Patrones y resultados del cambio de anticoagulantes orales directos en la fibrilación auricular no valvular: experiencia en la práctica clínica en España, Revista Clínica Española, 10.1016/j.rce.2023.03.007, 223, 6, (340-349), (2023).
- Clara Bonanad, Francisca Esteve-Claramunt, Sergio García-Blas, Ana Ayesta, Pablo Díez-Villanueva, Jose-Ángel Pérez-Rivera, José Luis Ferreiro, Joaquim Cánoves, Francisco López-Fornás, Albert Ariza Solé, Sergio Raposerias, David Vivas, Regina Blanco, Daznia Bompart Berroterán, Alberto Cordero, Julio Núñez, Lorenzo Fácila, Iván J. Núñez-Gil, José Luis Górriz, Vicente Bodí, Manuel Martínez-Selles, Juan Miguel Ruiz Nodar, Francisco Javier Chorro, Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes, Journal of Clinical Medicine, 10.3390/jcm11113008, 11, 11, (3008), (2022).
- David Vivas, Juan Carlos Gómez-Polo, Isidre Vilacosta, Edoxabán: de los ensayos clínicos a la evidencia de la vida real, REC: CardioClinics, 10.1016/j.rccl.2021.09.005, 57, 1, (4-6), (2022).
- Gonzalo Barón-Esquivias, Inmaculada Roldán Rabadán, Antonio García Quintana, Juan José Cerezo Manchado, M. Isabel Antorrena Miranda, José Javier Gómez-Barrado, Matías Pérez Paredes, Enrique Santas, Javier Pindado Rodríguez, Jorge Andrés Muñoz-Robles, Desamparados Oliver-Miñarro, María Amparo Santamaría Ortiz, Seguridad y efectividad del edoxabán en la práctica clínica tras un año de seguimiento en España. Registro ETNA-AF-EUROPE, REC: CardioClinics, 10.1016/j.rccl.2021.03.002, 57, 1, (39-47), (2022).